24 March 2022

GSK Stockmann contributed to the publication of the IFLR M&A Report 2022: Luxembourg

The 2022 edition of the M&A Report has been published by The International Financial Law Review (IFLR), a market-leading financial law publication for in-house counsel and law firms specializing in financial law.

First published in 1982, IFLR is the industry’s source on corporate finance trends and strategies, with informed viewpoints from a network of global editors, journalists and contributors from leading law firms and corporate counsels.

In the new edition, leading M&A practitioners from across the globe discuss the evolving mergers and acquisitions landscape of their countries.

GSK Stockmann contributed to the publication: Dr. Marcus Peter (Partner at GSK Stockmann in Luxembourg) and Kate Yu Rao (Senior Associate at GSK Stockmann in Luxembourg) report on the Luxembourg market in the 2022 edition of the International Financial Law Review.

This article was originally published by IFLR and is available for download as a PDF file and free to access on the IFLR website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
  • 03.08.2021

    GSK Update: Cross-Border Distribution Directive implemented – What you should know

    Read more
Contact person

Dr. Marcus Peter, LL.M.

Partner

+352 271802-50

marcus.peter@gsk-lux.com

Kate Rao, LL.M.

Senior Associate

+352 271802-54

kate.rao@gsk-lux.com

© GSK Stockmann 2022